Citius Pharmaceuticals (CTXR) Prepaid Assets (2013 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Prepaid Assets came in at $304495.0 in Q1 2026, down 89.88% YoY from $3.0 million in Q1 2025, and down 91.39% on a QoQ basis from $3.5 million in Q4 2025.
Citius Pharmaceuticals (CTXR) Prepaid Assets (2013 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 13 years of Prepaid Assets data on file, last reported at $304495.0 in Q1 2026.
- Quarterly Prepaid Assets fell 89.88% year-over-year to $304495.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $304495.0 (down 89.88% YoY) and the FY2025 annual result came in at $1.4 million, down 48.32% from the prior year.
- Prepaid Assets declined to $304495.0 in Q1 2026, from $3.5 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $10.1 million in Q2 2024 to a low of $304495.0 in Q1 2026.
- A 5-year average of $4.5 million and a median of $3.0 million in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets surged 180.7% — and 2026, when it sank 89.88%.
- Tracing CTXR's Prepaid Assets over 5 years: stood at $5.4 million in 2022, then soared by 44.83% to $7.9 million in 2023, then tumbled by 63.82% to $2.8 million in 2024, then advanced by 24.23% to $3.5 million in 2025, then sank by 91.39% to $304495.0 in 2026.
- The last three Prepaid Assets figures came in at $304495.0 (Q1 2026), $3.5 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Citius Pharmaceuticals | 15.71 Mn | 15.71 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 304,495.00 |
| Dec 31, 2025 | 3.54 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 10.09 Mn |
| Mar 31, 2024 | 9.01 Mn |
| Dec 31, 2023 | 7.86 Mn |
| Sep 30, 2023 | 7.89 Mn |
| Jun 30, 2023 | 7.83 Mn |
| Mar 31, 2023 | 5.84 Mn |
| Dec 31, 2022 | 5.43 Mn |
| Sep 30, 2022 | 2.85 Mn |
| Jun 30, 2022 | 2.79 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Dec 31, 2021 | 2.52 Mn |
| Sep 30, 2021 | 2.74 Mn |
| Jun 30, 2021 | 1.27 Mn |